Inspire Medical Systems, Inc.(INSP)Earnings, Financials & Key RatiosInspire Medical Systems, Inc. (INSP) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the balance sheet remains healthy with a 0.04 debt-to-equity ratio, the sharp deceleration in revenue growth to 1.6% and persistent operating losses suggest that the current 51.04 forward P/E valuation may be difficult to justify.
Inspire Medical Systems, Inc. (INSP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Inspire Medical Systems, Inc. (INSP) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $0.10vs $0.28+136.3% | $205Mvs $200M+2.3% |
| Q1 2026 | Feb 11, 2026 | $1.65vs $0.69+139.1% | $269Mvs $266M+1.3% |
| Q4 2025 | Nov 3, 2025 | $0.38vs $0.15+353.3% | $225Mvs $262M-14.4% |
| Q3 2025 | Aug 4, 2025 | $0.45vs $0.22+104.5% | $217Mvs $214M+1.2% |
Recent stock market news and headlines for Inspire Medical Systems, Inc. (INSP)
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed.
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research
Key metrics vs top competitors for Inspire Medical Systems, Inc. (INSP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $50.08 | $1.44B | 10.24 | 13.6% | 15.95% | 19.77% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $15.43 | $1.06B | -5.08 | 7.93% | -9.2% | -68.29% | — | |
| $125.09 | $4.11B | -89.99 | 26.24% | -3.53% | -20.6% | — | |
| $83.83 | $107.63B | 22.47 | 8.43% | 13.2% | 9.78% | — | |
| $95.84 | $166.94B | 25.76 | 5.67% | 13.91% | 12.09% | — |
Inspire Medical Systems, Inc. (INSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Inspire Medical Systems, Inc. (INSP) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
May 4, 2026·SEC
Feb 11, 2026·SEC
Get notified when INSP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Inspire Medical Systems, Inc. (INSP) stock FAQ — growth, dividends, profitability & financials explained
Inspire Medical Systems, Inc. (INSP) reported $915.2M in revenue for fiscal year 2025. This represents a 5472% increase from $16.4M in 2016.
Inspire Medical Systems, Inc. (INSP) grew revenue by 13.6% over the past year. This is steady growth.
Yes, Inspire Medical Systems, Inc. (INSP) is profitable, generating $131.1M in net income for fiscal year 2025 (15.9% net margin).
Inspire Medical Systems, Inc. (INSP) has a return on equity (ROE) of 19.8%. This is reasonable for most industries.
Inspire Medical Systems, Inc. (INSP) generated $96.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
